Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based study
- 19 August 2023
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 79, 104947
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- COVID-19 Among Patients With Multiple SclerosisNeurology Neuroimmunology & Neuroinflammation, 2021
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registryAnnals of the Rheumatic Diseases, 2021
- The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysisNeurological Sciences, 2021
- Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple SclerosisJAMA Neurology, 2021
- Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple SclerosisAnnals of Neurology, 2021
- Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 InfectionJAMA Network Open, 2020
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple SclerosisJAMA Neurology, 2020
- The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 SubjectsJournal of the American Medical Directors Association, 2020
- Progress in the Treatment of Hodgkin’s LymphomaNew England Journal of Medicine, 2018
- Emerging effects of comorbidities on multiple sclerosisThe Lancet Neurology, 2010